Granulesindia – We are committed to excellence and driven by …
Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API, PFI and FD through …
Products – Granulesindia
In the API sector, Granules is among the largest manufacturers of first line of defence products (paracetamol, metformin, ibuprofen, guaifenesin & methocarbamol).
About Us – Granulesindia
We strive to provide access to safe, effective and affordable medicines to the people who need them. Here is how our key strengths help us achieve our objective.
Granules Pharmaceuticals Inc. (GPI) – Granulesindia
Granules Pharmaceuticals Inc. (GPI) is a 100% subsidiary of Granules India located in Chantilly, Virginia. GPI is a US FDA & DEA approved facility which spreads over 100,000 sft area, with …
This acquisition strengthens Granules’ portfolio and opens up growth opportunities in the integrated Generics space in coming years. Granules will provide finished dosages of the new …
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality …
We are Granules aceutical company, delivering safe, cost-efective, and high-quality medicines. Strategic partnerships, particularly in the United States, and investments in research and …
With this approval, the GLS facility is now deemed approved by the U.S. FDA, marking a major milestone for Granules India as it expands its finished dosage manufacturing capabilities. This …
Our Facilities – Granulesindia
Our Gagillapur unit is one of the largest single unit manufacturing site for PFIs and Finished Dosages which we are further adding to by increasing technology based capacities. In an …
Investor Centre – Granulesindia
Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. We manufacture high-quality API, FD, PFI and Speciality …